Sino-C
Sino-C is a Sinomenine (HY-15122) derivative with anticancer activity. Sino-C broadly disrupts cholesterol homeostasis by upregulating key genes such as SREBF2 and HMGCS1, leading to intracellular cholesterol accumulation and lipid droplet formation. Sino-C-induced metabolic dysregulation further triggers lipid peroxidation and endoplasmic reticulum (ER) stress, initiating a unique form of hybrid cell death including apoptotic (cleaved PARP) and necrotic-like features. Sino-C thus serves as a useful compound for research in colorectal cancer, lung cancer and breast cancer.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- 화학식: C25H25Cl2NO4S
- 분자량:506.44
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
In Vitro
Sino-C (0-20 μM, 48 h) exhibits broad-spectrum anticancer activity in CRC (HCT116, RKO, and MC38), lung cancer (A549 and NCI-H1299), and breast cancer (MDA-MB-231 and 4T1) cells[1].
Sino-C (0-20 μM, 24 h) exhibits significant anti-CRC effect in HCT116 and RKO cells[1].
Sino-C (0-20 μM, 24 h) induces HCT116 and RKO cell death, characterized by PARP cleavage without caspase-3 activation, causes severe morphological alterations (widened perinuclear spaces, extensive ER dilation with ribosome detachment, mitochondrial swelling) along with significant LDH leakage and membrane injury, suggesting a non-apoptotic mechanism[1].
Sino-C (24 h) elicits a unique form of cell death: the morphological features do not match those of classical apoptosis, paraptosis, pyroptosis, or ferroptosis, but instead represent a hybrid mode combining both apoptotic and necrotic-like characteristics in HCT116 cells[1].
Sino-C (0-20 μM, 24 h) upregulates cholesterol homeostasis-related genes, elevates intracellular cholesterol levels, and induces lipid droplet accumulation in HCT116 cells[1].
Sino-C (0-20 μM, 24 h) induces cholesterol dysregulation, which leads to lipid peroxidation and subsequently triggers endoplasmic reticulum (ER) stress, ultimately contributing to CRC cell death[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HCT116, RKO, MC38, A549, NCI-H1299, MDA-MB-231, 4T1
-
Concentration:1.25, 2.5, 5, 10 and 20 μM
-
Incubation Time:48 h
-
Result:Significantly reduced cell viability in all tested cell lines in a dose-dependent manner, with IC50 values predominantly below 10 μM.
Showed greater potency against CRC cell lines, with IC50 values of 5.15 μM (HCT116), 9.72 μM (RKO), and 4.58 μM (MC38).
-
Cell Line:HCT116 and RKO cells
-
Concentration:0, 5, 10 and 20 μM
-
Incubation Time:24 h
-
Result:Remarkably inhibited the colony formation of HCT116 and RKO cells.
-
Cell Line:HCT116 and RKO cells
-
Concentration:0, 5, 10 and 20 μM
-
Incubation Time:24 h
-
Result:Revealed a dose-dependent increase in apoptosis: from 5.81% (control) to 26.80% (20 μM) in HCT116 cells from 5.39% to 22.34% in RKO cells.
Had minimal Annexin V+ staining in both cell lines, indicating a limited externalization of phosphatidylserine on the plasma membrane.
Increased in PI+ stained cells upon Sino-C treatment, suggesting that apoptosis may not be the only cell death mode.
-
Cell Line:HCT116 cells
-
Concentration:10 μM
-
Incubation Time:24 h
-
Result:Upregulated key genes involved in cholesterol homeostasis, including the master transcriptional Regulator of cholesterol biosynthesis, SREBF2, as well as rate-limiting enzymes and a key Receptor in the pathway, such as HMGCS1, SQLE, and LDLR.
-
Cell Line:HCT116 cells
-
Concentration:5, 10 and 20 μM
-
Incubation Time:24 h
-
Result:Markedly elevated intracellular cholesterol levels.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:HCT116 cells (1 × 106, s.c.) induce- BALB/c nude mice[1]
-
Dosage:30 and 50 mg/kg
-
Administration:i.t., every other day from day 14 to day 22 (30 mg/kg) then i.t., every other day from day 24 to day 28 (50 mg/kg)
-
Result:Significantly reduced tumor size and average tumor weight by approximately 43.24%.
Suppressed tumor growth over the two-week study period.
Caused no significant changes in mouse body weight, indicating minimal systemic toxicity.
Chemical Information
-
분자량 506.44
-
화학식 C25H25Cl2NO4S
-
SMILES
O=C1C[C@@]2(CCN3C)C4=C(O)C(O)=CC=C4[C@@H](SCC5=CC=C(Cl)C=C5Cl)[C@@]3([H])C2C=C1OC
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocol
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
순도&문서
References
[1]. Zhang YM, et al. Sino-C, a novel sinomenine derivative, induces cell death bya novel sinomenine derivative, induces cell death by disrupting cholesterol homeostasis in colorectal cancer cells. Acta Pharmacol Sin. 2025 Nov 3. doi: 10.1038/s41401-025-01683-8. Epub ahead of print. PMID: 41184618. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)